홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Diisopropylethylamine → 4-{5-[(6,7-Dichloro-1-oxo-1,2-dihydropyrrolo[1,2-a]pyrazin-4-yl)methyl]-2-fluorophenyl}-1-methyl-3,5-dioxopiperazin-1-ium trifluoroacetate

HRID 1172803
노트
인쇄 미리보기

반응식

HRID 1172803 반응식
[CH3:1][N:2]1[CH2:7][C:6](=[O:8])O[C:4](=[O:9])[CH2:3]1.[F:10][C:11]([F:16])([F:15])[C:12]([O-:14])=[O:13].[Cl:17][C:18]1[N:22]2[C:23]([CH2:28][C:29]3[CH:30]=[CH:31][C:32]([F:36])=[C:33]([NH3+:35])[CH:34]=3)=[CH:24][NH:25][C:26](=[O:27])[C:21]2=[CH:20][C:19]=1[Cl:37].CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.[B-](F)(F)(F)F.CCN(C(C)C)C(C)C>C1(C)C=CC=CC=1.CN(C1C=CN=CC=1)C.O.CC#N>[F:10][C:11]([F:16])([F:15])[C:12]([O-:14])=[O:13].[Cl:17][C:18]1[N:22]2[C:23]([CH2:28][C:29]3[CH:30]=[CH:31][C:32]([F:36])=[C:33]([N:35]4[C:4](=[O:9])[CH2:3][NH+:2]([CH3:1])[CH2:7][C:6]4=[O:8])[CH:34]=3)=[CH:24][NH:25][C:26](=[O:27])[C:21]2=[CH:20][C:19]=1[Cl:37]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

9

반응물 4

HCID 81531DiisopropylethylamineHCID 2733207O-(Benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborateHCID 143203244-Methylmorpholine-2,6-dioneHCID 866334295-[(6,7-Dichloro-1-oxo-1,2-dihydropyrrolo[1,2-a]pyrazin-4-yl)methyl]-2-fluorobenzenaminium trifluoroacetate

생성물 1

HCID 86633434
4-{5-[(6,7-Dichloro-1-oxo-1,2-dihydropyrrolo[1,2-a]pyrazin-4-yl)methyl]-2-fluorophenyl}-1-methyl-3,5-dioxopiperazin-1-ium trifluoroacetate

시약·촉매·용매 4

HCID 142844-(Dimethylamino)pyridine촉매HCID 962Water용매HCID 1140Toluene용매HCID 6342Acetonitrile용매

실험 절차

To a solution of 4-methylmorpholine-2,6-dione (1 eq) (see for Ref. WO 03/093261) in toluene (0.06 M) was added N2 (Example 14, step 2). The reaction mixture was refluxed for 2 h and then allowed to stand at RT overnight. The solvent was removed under reduced pressure. The resulting crude was dissolved in DMF (0.2 M) and to the resulting solution were added sequentially TBTU (1.3 eq), DIPEA (2.2 eq) and DMAP (0.3 eq). The mixture was stirred at RT for 2 h and then the product was isolated by purification at prep RP-HPLC using H2O (+0.1% TFA) and MeCN (+0.1% TFA) as eluents (C18 column). The desired fractions were lyophilized to afford the desired compound as a white powder. 1H NMR (400 MHz, DMSO-d6+TFA) δ: 7.41-7.27 (2H, m), 7.14 (1H, s), 7.08 (1H, d, J=6.8 Hz), 6.59 (1H, br. s), 4.38 (2H, s), 4.25 (4H, m), 2.85 (3H, s). MS (ES) C19H15Cl2FN4O3 requires: 436/438, found: 437/439 (M+H)+.

후처리

  1. temperatureThe reaction mixture was refluxed for 2 h
  2. customThe solvent was removed under reduced pressure
  3. dissolutionThe resulting crude was dissolved in DMF (0.2 M) and to the resulting solution
  4. customthe product was isolated by purification at prep RP-HPLC

출처 및 근거

ORD 기록
ord-c1f1a265a458444ba2cfc89ec791758f
출처 데이터셋
uspto-grants-2010_11
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07834015B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트